Pharmafile Logo
Pharmafocus logo
Advanced Search

outlook

Showing 8 posts of 8 posts found.

stocks3

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016
Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …

News
novo_nordisk_flag

Novo Nordisk Q1 operating profit down 10% in local currencies

April 29, 2016
Medical Communications, Sales and Marketing Financial, Novo Nordisk, Q1, earnings, outlook, results

Denmark’s Novo Nordisk (NYSE: NOV) on Friday posted a 10% drop in first-quarter operating profit and said it maintains its full year …

News
sanofi_hq__boetie_hall

Sanofi confirm 2016 outlook with Q1 results, EPS rises 5.3%

April 29, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2016, Q1, Sanofi, earnings, outlook, results

Sanofi (EPA: SAN) has confirmed its outlook for 2016 with the publication of their first quarter results, with earnings per …

News
astrazeneca_sign_sky

AstraZeneca Q1 earnings down 12%; maintains FY view

April 29, 2016
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results

UK drugmaker AstraZeneca (LSE: AZN) on Friday reported a 12% drop in first-quarter earnings and said it plans to streamline …

News
baxter

Baxter hikes 2016 earnings view driven by strong Q1 results

April 27, 2016
Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue

Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …

News
actelion_logo

Actelion ups outlook for 2016, reports Q1 net income up 12%

April 22, 2016
Medical Communications, Sales and Marketing Actelion, Biotechnology, Q1 results, earnings, outlook

Swiss biotech company Actelion (VTX: ATLN) raised its outlook for 2016 and reported a 12% rise in first quarter net …

News

Illumina shares plunge as it cuts Q1 outlook

April 20, 2016
Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market

Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …

News
bi_microparts_image

Boehringer Ingelheim posts 11% rise in FY15 sales boosted by diabetes business

April 20, 2016
Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, FY, earnings, forecasts, outlook, results

Boehringer Ingelheim reported 11% jump in sales for 2015 driven by its diabetes business and said for 2016 it sees …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026